The funding will deepen research into advanced biomarker modeling. Doctors say the company’s tools could streamline patient evaluations. The valuation reflects confidence in long-term impact.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
